Nantahala Capital Management »

Agios Pharmaceuticals shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.0M 100k 40.14

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Agios Pharmaceuticals

Farallon Capital Management
Vanguard Group
BlackRock
Bellevue Group
Paradigm Biocapital Advisors
Erste Asset Management GmbH
Wellington Management Company
Commodore Capital
State Street Corporation
Caligan Partners
Macquarie Group
Armistice Capital
TCG Crossover Management
Geode Capital Management
Frazier Life Sciences Management

View all funds holding Agios Pharmaceuticals